Skip to main content

Genotype of PAX2-related disorders

Genotype of PAX2-related disorders correlates with kidney and ocular manifestations


PAX2-related disorders encompass renal coloboma syndrome (RCS) and hereditary focal segmental glomerulosclerosis (FSGS) type 7. We retrospectively analyzed 27 Korean patients with PAX2 pathogenic variants detected between 2004 and 2022 and conducted a literature review of 328 cases, including 301 previously reported. In our cohort, 19 had RCS, 4 had FSGS, and 4 had isolated congenital anomalies of the kidneys and urinary tract.

Patients were classified by variant type into predicted loss of function (pLoF) and non-pLoF variant groups, and by variant location into paired domain and other sites group. pLoF variants were predominantly associated with RCS, observed in 82% of patients in both our data (18 of 22, P = 0.017) and the literature (140 of 171, P < 0.001). Kidney failure developed in 52% of Korean patients at a median age of 14.5 years, with no difference in kidney survival between variant types.

However, the literature review indicated faster progression to kidney failure in patients with pLoF variants (11.0 vs. 24.0 years; pLoF, n = 138 vs. non-pLoF, n = 71; P = 0.002), with no significant difference by variant location. Ocular manifestations were more common, had earlier onset, and were more severe in the pLoF variants group in our cohort (P = 0.038). The literature confirmed a higher prevalence of ocular involvement in patients with pLoF variants (pLoF, n = 175 vs. non-pLoF, n = 88; P < 0.001) and in those with paired domain variants (P = 0.01). pLoF variants in PAX2 were associated with worse kidney and ocular outcomes.

These findings support genotype-phenotype correlations, contributing to tailored management in patients with PAX2-related disorders.In conclusion, the clinical phenotypes of PAX2 pathogenic variants, including RCS, FSGS, and isolated CAKUT, were highly variable. A clear genotype-phenotype correlation was observed in both kidney and ocular manifestations. The pLoF variants were predominantly associated with RCS and exhibited a worse kidney prognosis compared to the non-pLoF variants in literature reviews, although this was not significant in our study.

The kidney survival did not differ by variant location. The pLoF variants were also associated with more common occurrence, earlier onset, and severe ocular involvement, which was not confined to the optic disc. The ocular involvement was more common in paired domain variants than in other sites. These insights demonstrate the significant implications of the genotype-based analysis approach in facilitating targeted and expedited patient care.

PAX2 gene, renal coloboma syndrome, CAKUT, optic nerve hypoplasia, transcription factor, autosomal dominant, gene mutation, developmental disorder, nephropathy, optic disc anomaly, missense mutation, nonsense mutation, frameshift mutation, kidney malformation, syndromic disorder, congenital defect, genotype-phenotype correlation, molecular diagnosis, hereditary nephropathy, eye development

#PAX2, #RenalColobomaSyndrome, #CAKUT, #GeneticDisorder, #KidneyDisease, #OpticNerveHypoplasia, #GeneMutation, #AutosomalDominant, #CongenitalAnomalies, #MolecularGenetics, #HereditaryDisorders, #MissenseMutation, #FrameshiftMutation, #PediatricNephrology, #EyeDevelopment, #SyndromicDisorder, #PAX2Mutation, #Nephropathy, #GeneticCounseling, #RareDisease

Comments

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...

Type of Inherited Blindness in Dogs

Genetic test could eradicate a type of inherited blindness in dogs A mountain rescue dog whose duties ended after her eyesight failed has helped scientists create a test that could eradicate the genetic eye condition in her breed for good. Shola the English shepherd has an inherited eye disease called progressive retinal atrophy (PRA) that causes the light-sensitive cells at the back of the eye to deteriorate, eventually leading to blindness. PRA affects more than 100 dog breeds, can be caused by a number of different genetic variants and has no treatment. For some types, symptoms do not appear until the dog is several years old , by which point they may have passed their genes on to puppies. Katherine Stanbury, the first author of the research from the University of Cambridge, said Shola was four years old when she began struggling with her vision in dim light. “She was sent to a veterinary ophthalmologist and they confirmed that she had PRA,” said Stanbury. “And then it turned out h...